The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
Open accessAbstract
Importance: Although IgA nephropathy (IgAN) is the most common glomerulonephritis in the world, there is no validated tool to predict disease progression. This limits patient-specific risk stratification and treatment decisions, clinical trial recruitment, and biomarker validation. Objective: To derive and externally validate a prediction model for disease progression in IgAN that can be applied at the time of kidney biopsy in multiple ethnic groups worldwide. Design, Setting, and Participants: We derived and externally validated a prediction model using clinical and histologic risk factors that are readily available in clinical practice. Large, multi-ethnic cohorts of adults with biopsy-proven IgAN were included from Europe, North America, China, and Japan. Main Outcomes and Measures: Cox proportional hazards models were used to analyze the risk of a 50% decline in estimated glomerular filtration rate (eGFR) or end-stage kidney disease, and were evaluated using the R2D measure, Akaike information criterion (AIC), C statistic, continuous net reclassification improvement (NRI), integrated discrimination improvement (IDI), and calibration plots. Results: The study included 3927 patients; mean age, 35.4 (interquartile range, 28.0-45.4) years; and 2173 (55.3%) were men. The following prediction models were created in a derivation cohort of 2781 patients: a clinical model that included eGFR, blood pressure, and proteinuria at biopsy; and 2 full models that also contained the MEST histologic score, age, medication use, and either racial/ethnic characteristics (white, Japanese, or Chinese) or no racial/ethnic characteristics, to allow application in other ethnic groups. Compared with the clinical model, the full models with and without race/ethnicity had better R2D (26.3% and 25.3%, respectively, vs 20.3%) and AIC (6338 and 6379, respectively, vs 6485), significant increases in C statistic from 0.78 to 0.82 and 0.81, respectively (ΔC, 0.04; 95% CI, 0.03-0.04 and ΔC, 0.03; 95% CI, 0.02-0.03, respectively), and significant improvement in reclassification as assessed by the NRI (0.18; 95% CI, 0.07-0.29 and 0.51; 95% CI, 0.39-0.62, respectively) and IDI (0.07; 95% CI, 0.06-0.08 and 0.06; 95% CI, 0.05-0.06, respectively). External validation was performed in a cohort of 1146 patients. For both full models, the C statistics (0.82; 95% CI, 0.81-0.83 with race/ethnicity; 0.81; 95% CI, 0.80-0.82 without race/ethnicity) and R2D (both 35.3%) were similar or better than in the validation cohort, with excellent calibration. Conclusions and Relevance: In this study, the 2 full prediction models were shown to be accurate and validated methods for predicting disease progression and patient risk stratification in IgAN in multi-ethnic cohorts, with additional applications to clinical trial design and biomarker research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran, D. C., Coppo, R., Cook, H. T., Feehally, J., Roberts, I. S. D., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.243 · Cited by 1,235
Self-citationTrimarchi, H., Barratt, J., Cattran, D. C., Cook, H. T., Coppo, R., Haas, M., Liu, Z.-H., Roberts, I. S. D., Yuzawa, Y., Zhang, H., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.003 · Cited by 1,192
Self-citationA Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts, I. S. D., Cook, H. T., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., Berthoux, F., Bonsib, S., Bruijn, J. A., et al. (2009) · Kidney International · doi:10.1038/ki.2009.168 · Cited by 1,038
Self-citation(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.9 · Cited by 966
External validation of a Cox prognostic model: principles and methods
Royston, P., & Altman, D. G. (2013) · BMC Medical Research Methodology · doi:10.1186/1471-2288-13-33 · Cited by 911
Intensive supportive care plus immunosuppression in IgA nephropathy
Rauen, T., Eitner, F., Fitzner, C., Sommerer, C., Zeier, M., Otte, B., Panzer, U., Peters, H., Benck, U., Mertens, P. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1415463 · Cited by 726
Donadio, J. V., & Grande, J. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020109 · Cited by 661
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
Reich, H. N., Troyanov, S. A. A., Scholey, J. W., & Cattran, D. C. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050526 · Cited by 639
Self-citationLevey, A. S., Inker, L. A., Matsushita, K., Greene, T., Willis, K., Lewis, E., de Zeeuw, D., Cheung, A. K., & Coresh, J. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.07.030 · Cited by 620
Debray, T. P. A., Vergouwe, Y., Koffijberg, H., Nieboer, D., Steyerberg, E. W., & Moons, K. G. M. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.06.018 · Cited by 597
Lv, J., Zhang, H., Wong, M. G., Jardine, M. J., Hladunewich, M., Jha, V., Monaghan, H., Zhao, M., Barbour, S., Reich, H., et al. (2017) · JAMA · doi:10.1001/jama.2017.9362 · Cited by 540
Self-citationCorticosteroids in IgA nephropathy: a randomised controlled trial
Pozzi, C., Bolasco, P., Fogazzi, G., Andrulli, S., Altieri, P., Ponticelli, C., & Locatelli, F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03563-6 · Cited by 532
Coppo, R., on behalf of the VALIGA study of the ERA-EDTA Immunonephrology Working Group, Troyanov, S., Bellur, S., Cattran, D., Cook, H. T., Feehally, J., Roberts, I. S. D., Morando, L., Camilla, R., et al. (2014) · Kidney International · doi:10.1038/ki.2014.63 · Cited by 498
Self-citationBarratt, J., & Feehally, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020134 · Cited by 386
Self-citationPredicting progression in IgA nephropathy
Bartosik, L. P., Lajoie, G., Sugar, L., & Cattran, D. C. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27689 · Cited by 363
Self-citationPredicting the Risk for Dialysis or Death in IgA Nephropathy
Berthoux, F., Mohey, H., Laurent, B., Mariat, C., Afiani, A., & Thibaudin, L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040355 · Cited by 361
Manno, C., Torres, D. D., Rossini, M., Pesce, F., & Schena, F. P. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp356 · Cited by 311
A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy
Haas, M., Verhave, J. C., Liu, Z.-H., Alpers, C. E., Barratt, J., Becker, J. U., Cattran, D., Cook, H. T., Coppo, R., Feehally, J., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040433 · Cited by 307
Self-citationThe MEST score provides earlier risk prediction in lgA nephropathy
Barbour, S. J., Espino-Hernandez, G., Reich, H. N., Coppo, R., Roberts, I. S. D., Feehally, J., Herzenberg, A. M., Cattran, D. C., Bavbek, N., Cook, T., et al. (2016) · Kidney International · doi:10.1038/ki.2015.322 · Cited by 292
Self-citationMaes, B. D., Oyen, R., Claes, K., Evenepoel, P., Kuypers, D., Vanwalleghem, J., Damme, B. V., & Vanrenterghem, Y. F. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00588.x · Cited by 269
Coppo (2007) · doi:10.1681/asn.2006040347 · Cited by 256
Goto, M., Wakai, K., Kawamura, T., Ando, M., Endoh, M., & Tomino, Y. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp273 · Cited by 255
Li, P. K.-T., Leung, C. B., Chow, K. M., Cheng, Y. L., Fung, S. K.-S., Mak, S. K., Tang, A. W.-C., Wong, T. Y.-H., Yung, C. Y., Yung, J. C.-U., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.01.017 · Cited by 223
Validation of the Oxford classification of IgA nephropathy
Herzenberg, A. M., Fogo, A. B., Reich, H. N., Troyanov, S., Bavbek, N., Massat, A. E., Hunley, T. E., Hladunewich, M. A., Julian, B. A., Fervenza, F. C., et al. (2011) · Kidney International · doi:10.1038/ki.2011.126 · Cited by 211
Self-citationSeveral methods to assess improvement in risk prediction models: Extension to survival analysis
Chambless, L. E., Cummiskey, C. P., & Cui, G. (2011) · Statistics in Medicine · doi:10.1002/sim.4026 · Cited by 194
A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study
Wakai, K., Kawamura, T., Endoh, M., Kojima, M., Tomino, Y., Tamakoshi, A., Ohno, Y., Inaba, Y., & Sakai, H. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl342 · Cited by 178
Risk Stratification of Patients With IgA Nephropathy
Barbour, S. J., & Reich, H. N. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.02.326 · Cited by 174
Self-citationBarbour, S. J., Cattran, D. C., Kim, S. J., Levin, A., Wald, R., Hladunewich, M. A., & Reich, H. N. (2013) · Kidney International · doi:10.1038/ki.2013.210 · Cited by 164
Self-citationInker, L. A., Heerspink, H. J. L., Mondal, H., Schmid, C. H., Tighiouart, H., Noubary, F., Coresh, J., Greene, T., & Levey, A. S. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.017 · Cited by 163
Predicting Progression of IgA Nephropathy: New Clinical Progression Risk Score
Xie, J., Kiryluk, K., Wang, W., Wang, Z., Guo, S., Shen, P., Ren, H., Pan, X., Chen, X., Zhang, W., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038904 · Cited by 149
The impact of sex in primary glomerulonephritis
Cattran, D. C., Reich, H. N., Beanlands, H. J., Miller, J., Scholey, J. W., Troyanov, S., & for the Genes, G. A. G. G. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm919 · Cited by 145
Self-citationAddition of Azathioprine to Corticosteroids Does Not Benefit Patients with IgA Nephropathy
Pozzi, C., Andrulli, S., Pani, A., Scaini, P., Vecchio, L. D., Fogazzi, G., Vogt, B., Cristofaro, V. D., Allegri, L., Cirami, L. C., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010117 · Cited by 143
Hogg, R. J., Lee, J. Y., Nardelli, N., Julian, B. A., Cattran, D., Waldo, B., Wyatt, R. J., Jennette, J. C., Sibley, R. K., Hyland, Κ., et al. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01020905 · Cited by 133
Self-citationDevelopment and Validation of a Prediction Rule Using the Oxford Classification in IgA Nephropathy
Tanaka, S., Ninomiya, T., Katafuchi, R., Masutani, K., Tsuchimoto, A., Noguchi, H., Hirakata, H., Tsuruya, K., & Kitazono, T. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03480413 · Cited by 125
Self-citationImmunosuppressive agents for treating IgA nephropathy
Vecchio, M., Bonerba, B., Palmer, S. C., Craig, J. C., Ruospo, M., Samuels, J., Molony, D. A., Schena, F. P., & Strippoli, G. F. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003965.pub2 · Cited by 119
Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy
Berthoux, F. C., Mariat, C., & Maillard, N. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft286 · Cited by 69
Pesce, F., Diciolla, M., Binetti, G., Naso, D., Ostuni, V. C., Noia, T. D., Vågane, A. M., Bjørneklett, R. O., Suzuki, H., Tomino, Y., et al. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv232 · Cited by 56
Knoop, T., Vågane, A. M., Vikse, B. E., Svarstad, E., Magnúsdóttir, B. T., Leh, S. M., Reisæter, A. V., & Bjørneklett, R. O. (2015) · American Journal of Nephrology · doi:10.1159/000381403 · Cited by 34
Sun, L., Shang, J., Xiao, J., & Zhao, Z. (2020) · PeerJ · doi:10.7717/peerj.8499 · Cited by 31
Obrișcă, B., Sinescu, I. C., Ismail, G., & Mircescu, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101584 · Cited by 11
Song, H., Hu, H., Tang, F., Cao, C., Wan, Q., & He, Y. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8573 · Cited by 2
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
Rovin, B. H., Adler, S. G., Barratt, J., Bridoux, F., Burdge, K. A., Chan, T. M., Cook, H. T., Fervenza, F. C., Gibson, K. L., Glassock, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.021 · Cited by 2,518
Self-citationThe pathogenesis of IgA nephropathy and implications for treatment
Cheung, C. K., Alexander, S., Reich, H. N., Selvaskandan, H., Zhang, H., & Barratt, J. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00885-3 · Cited by 222
Self-citationRovin, B. H., Barratt, J., Cook, H. T., Noronha, I. L., Reich, H. N., Suzuki, Y., Tang, S. C. W., Trimarch, H., & Floege, J. (2025) · Kidney International · doi:10.1016/j.kint.2025.04.004 · Cited by 206
Self-citationIgA nephropathy: Update on pathogenesis and treatment
Ramsawak, S., Cohen, S., Linares, A., & Cavanaugh, C. (2025) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.92a.24105 · Cited by 23
Metadata
- Authors
- Barbour, S. J., Coppo, R., Zhang, H., Liu, Z.-H., Suzuki, Y., Matsuzaki, K., Katafuchi, R., Er, L., Espino-Hernandez, G., Kim, S. J., Reich, H. N., Feehally, J., Cattran, D. C., & International IgA Nephropathy Network
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2019-07-01
- Volume
- 179
- Issue
- 7
- Pages
- 942
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2937346600
- Cited by
- 478
- References
- 44
- FWCI
- 29.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.